Treatment Overview
Transurethral Resection of Bladder Tumor (TURBT) is a minimally invasive procedure for diagnosing and treating bladder cancer. It involves inserting a resectoscope through the urethra to remove tumors from the bladder lining without making external incisions. In Korea, TURBT is performed using advanced high-definition endoscopic systems, laser-assisted technology, and narrow-band imaging for precise tumor visualization. It is the standard first-line surgical treatment for non-muscle-invasive bladder cancer (NMIBC) and is often combined with intravesical therapy to reduce recurrence. Korean hospitals provide seamless care for both local and international patients, offering high safety standards, fast scheduling, and experienced urology specialists.
Purpose & Benefits
The main purpose of TURBT is to remove visible bladder tumors, establish an accurate histopathological diagnosis, and prevent tumor progression. Key benefits include:
– Minimally invasive approach with no external incisions
– Short hospital stay and faster recovery
– Accurate tumor staging and grading via tissue biopsy
– Reduced risk of complications compared to open surgery
– Can be repeated multiple times for recurrent tumors
– Effective first-line therapy for early-stage bladder cancer
Patients benefit from Korea’s state-of-the-art endoscopic systems, ensuring thorough tumor removal with minimal trauma to healthy tissue.
Ideal Candidates
TURBT is suitable for:
– Patients with non-muscle-invasive bladder cancer (Ta, T1)
– Individuals with small or medium-sized bladder tumors
– Patients requiring diagnostic tissue sampling
– Individuals with recurrent superficial bladder tumors
– Patients seeking a minimally invasive, bladder-preserving approach
Eligibility is determined through cystoscopy, imaging, and urine cytology to ensure proper tumor assessment.
Possible Risks & Complications
Although TURBT is generally safe, potential risks include:
– Bleeding during or after surgery
– Bladder perforation (rare)
– Infection or urinary tract infection (UTI)
– Incomplete tumor removal, necessitating repeat procedures
– Urinary frequency, urgency, or mild discomfort post-surgery
– Anesthesia-related complications
Korean hospitals maintain very low complication rates due to meticulous surgical technique and advanced imaging for precise tumor removal.
Techniques & Technology Used
Korea is at the forefront of TURBT technology, using advanced equipment and techniques:
– High-Definition Cystoscopy: Provides detailed visualization of tumors
– Narrow-Band Imaging (NBI): Enhances detection of flat or subtle lesions
– Blue-Light Cystoscopy: Improves identification of carcinoma in situ
– Laser-Assisted TURBT: Reduces bleeding and improves precision
– Electrocautery Resection: Standard technique for safe tumor excision
– Intraoperative Pathology: Confirms complete removal and margins
These technologies improve tumor detection, reduce recurrence, and minimize postoperative complications.
Treatment Process in Korea
The TURBT treatment pathway for international patients is highly organized:
- Pre-Arrival Consultation: Review of medical records, imaging, and biopsy reports; cost estimation and travel planning.
- Diagnostic Workup: Cystoscopy, imaging (CT/MRI), urine cytology, and blood tests.
- Multidisciplinary Review: Urologists and oncologists confirm tumor staging and select the appropriate TURBT approach.
- Surgery: Performed under general or spinal anesthesia; tumors are resected and tissue sent for histopathology.
- Postoperative Monitoring: Observation for bleeding, infection, and urinary function; catheter use for 1–2 days if needed.
- Discharge: Most patients leave the hospital the same day or within 24 hours.
- Follow-Up: Regular cystoscopy and intravesical therapy to prevent recurrence.
Recovery & After-Care
Recovery from TURBT is generally quick:
– Most patients resume normal activities within 1–2 days
– Mild urinary discomfort and frequency may persist for a few days
– Catheter removal typically occurs within 1–2 days
– Drinking plenty of fluids to flush the bladder
– Regular follow-up cystoscopy is essential to monitor for tumor recurrence
Korean hospitals provide post-surgery care instructions and schedule follow-ups to ensure optimal recovery and long-term monitoring.
Results & Longevity
TURBT in Korea provides excellent outcomes for non-muscle-invasive bladder cancer:
– High rates of complete tumor removal
– Low complication rates
– Allows repeated interventions for recurrent tumors
– Combined with intravesical therapy, TURBT significantly reduces recurrence risk
– Preserves bladder function and quality of life
Patients experience excellent long-term disease management with appropriate follow-up.
Why Korea Is a Top Destination
Korea is a preferred destination for TURBT due to:
– Expert urologists specializing in bladder cancer
– Advanced endoscopic and laser technology
– Rapid scheduling and efficient treatment process
– Multilingual support for international patients
– High safety standards and low complication rates
– Affordable treatment costs compared to the US and Europe
– Comprehensive after-care and follow-up programs
These factors ensure safe, precise, and effective bladder tumor removal for medical tourists.
Cost Range
Typical costs for TURBT in Korea include:
– Standard TURBT: USD 3,000 – 7,000
– TURBT with laser assistance: USD 5,000 – 9,000
– Diagnostic imaging and pathology: USD 800 – 1,500
– Follow-up cystoscopy and intravesical therapy: USD 400 – 1,000
Costs usually cover diagnostics, surgery, hospitalization (usually outpatient), and follow-up care.
Popular Clinics in Korea
Top hospitals for TURBT in Korea include:
– Asan Medical Center
– Samsung Medical Center
– Seoul National University Hospital
– Severance Hospital (Yonsei University Health System)
– St. Mary’s Hospital
– Korea University Anam Hospital
– Specialized urology centers with high TURBT volume
These hospitals are recognized for their expertise in minimally invasive bladder cancer procedures and patient-centered care.
